Skip to content

Study on the Predictive Value of Cancer therapy-related cardiovascular toxicity Risk in Breast Cancer Patients

Study on the Predictive Value of Cancer therapy-related cardiovascular toxicity Risk in Breast Cancer Patients

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122484
Enrollment
Unknown
Registered
2026-04-14
Start date
2025-01-01
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Cancer Therapy-Related Cardiac Dysfunction:None
None Cancer Therapy-Related Cardiac Dysfunction:None

Sponsors

The Second Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Breast cancer patients who have received chemotherapy, targeted therapy, or surgical treatment; 2. Age: 18 to 85 years old; 3. The patient's expected survival period is greater than 12 months; 4. Patients with good compliance who voluntarily accept follow-up.

Exclusion criteria

Exclusion criteria: 1. Due to the severity of the condition, the patient is unable to tolerate the assessment of cardiac structure and function through imaging. 2. Have a history of drug abuse; 3. Inability to regularly follow up and recheck blood biomarkers and imaging indicators; 4. End-stage renal failure (defined as glomerular filtration rate less than 15ml/min.m2); 5. Combined with other malignant tumors.

Design outcomes

Primary

MeasureTime frame
Time from first presentation to all-cause or cardiovascular disease-related rehospitalization;Time from first presentation to all-cause or cardiovascular disease-related death;Change in left ventricular ejection fraction (LVEF) level;Changes in cardiac structural parameters, including left ventricular end-diastolic diameter (LVEDD), left atrial diameter, and four-chamber atrial diameter, etc.;

Secondary

MeasureTime frame
Cardiovascular Disease Risk Assessment Form;Eastern Cooperative Oncology Group (ECOG) Performance Status Scale;

Countries

China

Contacts

Public ContactZhang Yang

The Second Affiliated Hospital of Dalian Medical University

zhangyangzz@126.com+86 177 0987 6390

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026